CABRELLIS PHARMACEUTICALS
Cabrellis Pharmaceuticals Corporation, a specialty pharmaceutical company developing therapies for the treatment of cancer. Cabrellis plans to initiate three separate clinical trials in small cell lung cancer (SCLC) in 2006. The first trial, designed to assess the safety and efficacy of Calsed(TM) in reference to topotecan in the second-line treatment of patients with SCLC who previously responded to platinum-based chemotherapy, is currently underway at multiple clinical trial sites in the United States.
CABRELLIS PHARMACEUTICALS
Industry:
Health Care Health Diagnostics Pharmaceutical Therapeutics
Founded:
2006-01-01
Address:
San Diego, California, United States
Country:
United States
Total Employee:
11+
Status:
Active
Contact:
(858)404-1777
Total Funding:
27.5 M USD
Similar Organizations
Conforma Therapeutics
Conforma Therapeutics Corporation designs and develops drugs for the treatment of cancer.
Novita Pharmaceuticals
Novita Pharmaceuticals is a developer of therapeutic drugs for the treatment of cancer.
Therinject
Therinject is a pharmaceutical company focused on developing therapeutics for the treatment of cancer.
Investors List
Novo Holdings
Novo Holdings investment in Series A - Cabrellis Pharmaceuticals
Lilly Ventures
Lilly Ventures investment in Series A - Cabrellis Pharmaceuticals
RiverVest
RiverVest investment in Series A - Cabrellis Pharmaceuticals
Domain Associates
Domain Associates investment in Series A - Cabrellis Pharmaceuticals
RBC Venture Partners
RBC Venture Partners investment in Series A - Cabrellis Pharmaceuticals
Forward Ventures
Forward Ventures investment in Series A - Cabrellis Pharmaceuticals
SR One
SR One investment in Series A - Cabrellis Pharmaceuticals
ProQuest Investments
ProQuest Investments investment in Series A - Cabrellis Pharmaceuticals